Memphis Pharmaceuticals & Chemical Industries announced earnings results for the half year ended December 31, 2020. For the half year, the company announced total revenue was EGP 267.867 million compared to EGP 251.140 million a year ago. Operating income was EGP 19.301 million compared to EGP 4.347 million a year ago. Net income was EGP 18.815 million compared to EGP 3.339 million a year ago.